Stephen Zelkowicz
About Stephen J. Zelkowicz
Independent director of DLH Holdings Corp since July 2020; age 51. Career equity research analyst at Wynnefield Capital, Inc. since 1999, specializing in small-cap public companies. Education: B.A. University of Pennsylvania; M.B.A. Columbia University. Tenure on DLH Board: continuously since 2020.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Summer Infant, Inc. | Director | Aug 2014 – Jun 2022 | Chair – Governance & Nominating; Member – Compensation |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Wynnefield Capital, Inc. | Equity Research Analyst | 1999 – Present | Small-cap specialist investment firm |
Board Governance
- Independence: Board affirmed Zelkowicz as independent under Nasdaq rules; only CEO is non-independent.
- Committee assignments (FY2024): Chair – Management Resources & Compensation Committee; Member – Audit Committee.
- Committee activity: Compensation met 5 times (plus 2 unanimous written consents); Audit met 8 times (FY2024).
- Board meetings/attendance: Board met 9 times; no director below 75% attendance. Independent directors held executive sessions at all regularly scheduled meetings.
- Annual meeting attendance: All directors attended the Mar 14, 2024 annual meeting.
- Board leadership: Independent Chairman (Frederick G. Wasserman); roles of Chair and CEO separated. No Lead Independent Director identified.
Fixed Compensation (Director)
| Component (FY2024) | Amount | Notes |
|---|---|---|
| Annual Board retainer (cash) | $60,000 | Standard non-employee director retainer |
| Chair fee – Compensation Committee | $15,000 | Chair-specific |
| Audit Committee member fee | $7,500 | Member (non-chair) |
| Total Fees Earned (Cash) | $82,500 | Matches proxy table for Zelkowicz |
- Director fees are set relative to market median and reviewed annually by the Compensation Committee with consultant input.
Performance Compensation (Director)
| Equity Element | Grant Date | Shares/Units | Grant Value | Vesting | Notes |
|---|---|---|---|---|---|
| RSUs (annual grant) | Oct 1, 2023 | 8,569 | $100,000 (recognized expense) | Cliff vest Sep 30, 2024 | Grant value based on closing price; annual cadence October grants, September vest |
| RSUs (annual grant) | Oct 1, 2024 | 10,941 | Not shown in FY2024 expense table | Cliff vest Sep 30, 2025 | On substantially similar terms to prior year |
- RSU grant sizing references fair market value on grant date (closing price $11.67 on Sep 29, 2023 for Oct 1, 2023 grants).
- RSU vesting accelerates upon death, disability, or change in control per plan; unvested RSUs generally forfeit upon board service termination.
- Anti-hedging/anti-pledging: Directors prohibited from hedging or pledging DLH securities.
- Clawback: Company maintains a Nasdaq 10D-1 compliant compensation recovery policy; applies to incentive-based compensation (primarily executives).
Other Directorships & Interlocks
| Entity | Type | Relationship | Potential Interlock/Conflict Consideration |
|---|---|---|---|
| Wynnefield Capital funds (various) | Shareholder | Aggregate DLH ownership across Wynnefield vehicles: 126,487 – 1,854,044 shares (various funds), up to 12.9% in one vehicle | Zelkowicz is an analyst at Wynnefield; affiliation with significant shareholder may create perceived conflict or influence dynamics; Board still deems him independent under Nasdaq. |
| Committee interlocks | Governance | Company discloses no Compensation Committee interlocks with other companies | None identified. |
Expertise & Qualifications
- 20+ years capital markets and small-cap research experience; adds investor perspective to Board.
- Governance leadership background (prior chair of Governance & Nominating at Summer Infant).
- Academic credentials (UPenn BA; Columbia MBA).
Equity Ownership
| Holder | Shares Beneficially Owned | % of Outstanding | Notes |
|---|---|---|---|
| Stephen J. Zelkowicz | 35,435 | <1% | As of Jan 22, 2025 record date; outstanding shares 14,386,468. Excludes RSUs granted Oct 1, 2024 (not vesting within 60 days). |
| RSUs/Restricted stock held (as of Sep 30, 2024) | 32,935 | N/A | Outstanding restricted stock awards and shares issued under RSU grants beneficially owned at year-end; excludes Oct 1, 2024 grant. |
| RSU grant Oct 1, 2024 | 10,941 | N/A | Scheduled to cliff vest Sep 30, 2025. |
- Director stock ownership guideline: 5x annual cash retainer to be achieved within 5 years; directors met or are on track.
- Anti-hedging/pledging prohibition applies.
Say-on-Pay & Shareholder Feedback
- 2023 advisory say-on-pay approval ~92% (strong support); Board continues annual say-on-pay cadence.
Compensation Committee Analysis
- Compensation Committee chaired by Zelkowicz; independent members (Granger, Murphy, Yerks).
- Use of independent consultant: Korn Ferry engaged to advise on executive and director compensation (independence assessed; no conflicts).
- No repricing of equity awards permitted under plan; strong governance controls in equity programs.
Governance Assessment
-
Strengths:
- Clear independence designation; active executive sessions and strong attendance signal engaged oversight.
- Separation of Chair/CEO roles; independent chair enhances checks and balances.
- Transparent director pay program with modest cash retainer, committee differentials, and equity alignment; equity is a significant portion of total director compensation (cash $82.5k vs equity $100k in FY2024).
- Anti-hedging/pledging policy and stock ownership guidelines foster alignment.
-
Potential RED FLAGS/Monitoring:
- Affiliation with Wynnefield Capital, a significant shareholder (multiple Wynnefield funds collectively >5%); while independence is affirmed, this may raise perceived conflict or influence risks, particularly with Zelkowicz chairing Compensation. Ensure robust recusals and conflict management when matters directly affect Wynnefield interests.
- Director equity grants are time-based RSUs without performance conditions; typical for directors but offers lower direct pay-for-performance linkage.
-
No director-specific related-party transactions disclosed for Zelkowicz; company reviews and approves any material related-party transactions via independent Audit Committee/Board.
-
Committee workload appropriate (Audit 8 meetings; Compensation 5 + 2 consents), indicating active governance.